Quality of Sleep of Patients With Predominant Central Sleep Apnea Syndrome(SAS) Whose EF > 45% Treated by ASV

NCT02835638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2026-04-24

No results posted yet for this study

Summary

The main goal of this French multicenter observational cohort study is to prospectively collect data assessing the impact of the Adaptative Servo-Ventilation treatment on the quality of sleep of patients with central or combined sleep apnea syndrome (SAS) out of Heart Failure (HF) with altered ejection fraction, with a predominant central SAS.

Conditions

Interventions

DEVICE

Adaptative Servo Ventilation

the ASV treatment will be observed during this study on the patients included

Sponsors & Collaborators

  • Société Française de Recherche et de Médecine du Sommeil

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-26
Primary Completion
2021-09-21
Completion
2025-12-16

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02835638 on ClinicalTrials.gov